0001096906-24-000515.txt : 20240319
0001096906-24-000515.hdr.sgml : 20240319
20240319192423
ACCESSION NUMBER: 0001096906-24-000515
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Rourke Peter
CENTRAL INDEX KEY: 0001890749
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54296
FILM NUMBER: 24765736
MAIL ADDRESS:
STREET 1: C/O NORTHVIEW ACQUISITION CORP.
STREET 2: 207 WEST 25TH STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0001514946
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 274092986
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (212) 751-0001
MAIL ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AXIM INTERNATIONAL INC.
DATE OF NAME CHANGE: 20110309
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-15
0
0001514946
AXIM BIOTECHNOLOGIES, INC.
AXIM
0001890749
O'Rourke Peter
6191 CORNERSTONE COURT, E.
SUITE 114
SAN DIEGO
CA
92121
1
0
0
0
0
Convertible Note
0.0100
2024-03-15
4
A
0
35000.0000
35000.0000
A
2024-03-15
2034-03-01
Common Stock
3500000.0000
4500000.0000
D
Reporting Person acquired a convertible note, face value $35,000. The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share.
/s/ Peter O'Rourke
2024-03-18